193 related articles for article (PubMed ID: 24633991)
1. Longer survival in patients with human papillomavirus-related head and neck cancer after positive postradiation planned neck dissection.
Huang SH; Patel S; O'Sullivan B; Shen X; Xu W; Weinreb I; Perez-Ordonez B; Irish J; Waldron J; Gullane P; Gilbert R; Brown D; Kim J; Freeman J; de Almeida JR; Goldstein D
Head Neck; 2015 Jul; 37(7):946-52. PubMed ID: 24633991
[TBL] [Abstract][Full Text] [Related]
2. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
3. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease.
Huang SH; O'Sullivan B; Weinreb I; Perez-Ordonez B; Irish J; Waldron J; Gullane P; Gilbert R; Brown D; Cummings B; Kim J; Freeman J; Witterick I; Goldstein D
Head Neck; 2012 Jul; 34(7):913-22. PubMed ID: 21953822
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
[TBL] [Abstract][Full Text] [Related]
6. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
7. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
[TBL] [Abstract][Full Text] [Related]
8. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
9. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
11. Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery.
Stucken CL; de Almeida JR; Sikora AG; Tong CC; Genden EM
Head Neck; 2016 Mar; 38(3):380-6. PubMed ID: 25351893
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer.
Addison D; Seidelmann SB; Janjua SA; Emami H; Staziaki PV; Hallett TR; Szilveszter B; Lu MT; Cambria RP; Hoffmann U; Chan AW; Wirth LJ; Neilan TG
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855164
[TBL] [Abstract][Full Text] [Related]
13. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
14. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
15. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients.
Hoffmann M; Görögh T; Gottschlich S; Lohrey C; Rittgen W; Ambrosch P; Schwarz E; Kahn T
Cancer Lett; 2005 Feb; 218(2):199-206. PubMed ID: 15670897
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
17. Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.
Chen AM; Zahra T; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Vaughan AT
Head Neck; 2013 Nov; 35(11):1652-6. PubMed ID: 23335285
[TBL] [Abstract][Full Text] [Related]
18. Identification of human papillomavirus status specific biomarker in head and neck cancer.
Kim KY; Zhang X; Cha IH
Head Neck; 2015 Sep; 37(9):1310-8. PubMed ID: 24817691
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus in HNSCC: a European epidemiologic perspective.
Licitra L; Zigon G; Gatta G; Sánchez MJ; Berrino F;
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1143-53, vii-viii. PubMed ID: 19010264
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
